Celldex Therapeutics (CLDX) Debt Ratio (2010 - 2013)
Celldex Therapeutics (CLDX) posted quarterly Debt Ratio of 0.07 for Q1 2013, down 36.86% year-over-year from 0.11 in Q1 2012, and down 22.37% quarter-over-quarter from 0.09 in Q4 2012.
Celldex Therapeutics (CLDX) Debt Ratio (2010 - 2013) Analysis & Trends
Celldex Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.07 for Q1 2013.
- In Q1 2013, Debt Ratio fell 36.86% year-over-year to 0.07; the TTM figure through Mar 2013 stood at 0.07 (down 36.86% YoY), while the FY2012 annual figure was 0.09, down 41.56% from the prior year.
- Debt Ratio for Q1 2013 stood at 0.07, down from 0.09 in the prior quarter.
- The five-year high for Debt Ratio was 0.16 in Q2 2012, with the low at 0.07 in Q1 2013.
- The 4-year median for Debt Ratio is 0.11 (2012), against an average of 0.12.
- The sharpest annual moves came in 2011 and 2012: Debt Ratio soared 69.91% in 2011, then tumbled 41.56% in 2012.
- Celldex Therapeutics' Debt Ratio stood at 0.09 in 2010, then jumped by 69.91% to 0.15 in 2011, then sank by 41.56% to 0.09 in 2012, then slipped by 22.37% to 0.07 in 2013.
- Business Quant data shows CLDX's Debt Ratio at 0.07 in Q1 2013, 0.09 in Q4 2012, and 0.11 in Q3 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 0.07 |
| Dec 31, 2012 | 0.09 |
| Sep 30, 2012 | 0.11 |
| Jun 30, 2012 | 0.16 |
| Mar 31, 2012 | 0.11 |
| Dec 31, 2011 | 0.15 |
| Sep 30, 2011 | 0.14 |
| Jun 30, 2011 | 0.13 |
| Dec 31, 2010 | 0.09 |